Trial intelligence / Profile preview

Submucosal tramadol before inferior alveolar nerve block for mandibular molars with irreversible pulpitis

2013-004741-16Phase 4Active

Sponsor
Ana de Pedro Muñoz
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of tramadol in irreversible pulpitis, sponsored by Ana de Pedro Muñoz. Primary endpoint: Success of inferior alveolar nerve block. Started Jul 2014; status: active.

02

Drugs

tramadol
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on 2013-004741-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004741-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call